DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Optimark (Gadoversetamide) - General Physical Health Deterioration - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with General Physical Health Deterioration (62)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Optimark (Gadoversetamide) where reactions include general physical health deterioration. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 62   Next >>

Possible Optimark side effects in 49 year old male

Reported by a lawyer from United States on 2012-08-02

Patient: 49 year old male, weighing 77.1 kg (169.6 pounds)

Reactions: Pain, Joint Contracture, Erythema, Muscle Tightness, Joint Stiffness, Myosclerosis, Rash Pruritic, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Depression, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Skin Tightness, Skin Plaque, Joint Swelling, Quadriparesis, Mobility Decreased

Drug(s) suspected as cause:
Omniscan

Multihance
    Indication: Product Used FOR Unknown Indication

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-05-19
    End date: 2006-05-19

Magnevist
    Dosage: 15 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-10-13
    End date: 2006-10-13

Omniscan
    Dosage: 50 ml omniscan+co2
    Indication: Fistulogram
    Start date: 2006-08-04
    End date: 2006-08-04

Gadolinium IN Unspecified Drug
    Start date: 2004-05-19
    End date: 2004-05-19

Omniscan
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-08-05
    End date: 2006-08-05

Prohance
    Indication: Computerised Tomogram Head
    Start date: 2004-05-19
    End date: 2004-05-19

Optimark
    Indication: Product Used FOR Unknown Indication

Magnevist
    Dosage: 20 ml, unk
    Start date: 2006-10-17
    End date: 2006-10-17

Other drugs received by patient: Coumadin; Renagel; Aranesp; Lyrica; Norvasc; Lamisil; Percocet; Gentamicin; Procardia XL; Ferrous Sulfate TAB; Sodium Bicarbonate; Acetaminophen; Venofer; Coreg; Actos; Prinivil; Synthroid; Amitriptline Hydrochloride TAB; Nateglinide; Pentoxifylline; Phoslo; Procrit; Epogen; Nexium; Elavil; Lipitor; Lantus; Trental; Benadryl; Avelox; Pletal; Tambocor; Atenolol; Zyvox; Lopid; Nephrocaps; Bactrim DS; Restoril; Clonidine; Starlix; Accupril; Vancomycin; Lasix; Potassium Chloride; Glucotrol; Renagel; Nicotine



Possible Optimark side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient: 56 year old female

Reactions: Pruritus, Abasia, Pain, Joint Contracture, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Injury, Fibrosis, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, Rash, Skin Induration, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Mobility Decreased, Scar

Drug(s) suspected as cause:
Optimark
    Indication: Muscular Weakness

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-05-28
    End date: 1999-05-28

Optimark
    Indication: Disorientation

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-05-21
    End date: 2004-05-21

Optimark
    Indication: Headache

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-06-02
    End date: 2006-06-02

Magnevist
    Indication: Renal Mass

Other drugs received by patient: Lantus; Sensipar; Slow Release Iron; Prograf; Phoslo; Renvela; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Prednisone; Procrit; Atenolol



Possible Optimark side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient: female

Reactions: Pruritus, Pain, Joint Contracture, Myosclerosis, Skin Ulcer, Injury, Fibrosis, General Physical Health Deterioration, Skin Hypertrophy, Skin Induration, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Tendon Disorder, Disability

Drug(s) suspected as cause:
Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Angiogram

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Multihance
    Indication: Angiogram

Omniscan
    Indication: Angiogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging



Possible Optimark side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-27

Patient: female

Reactions: Pruritus, Pain, Muscle Contracture, General Physical Health Deterioration, DRY Skin, Nephrogenic Systemic Fibrosis, Deformity, Skin Plaque, Emotional Distress, Anxiety, Skin Ulcer, Arthralgia, Fibrosis, Injury, Disability

Drug(s) suspected as cause:
Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Angiogram

Magnevist
    Indication: Angiogram

Multihance
    Indication: Angiogram

Omniscan
    Indication: Angiogram

Optimark
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging



Possible Optimark side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24

Patient: 56 year old female

Reactions: Pruritus, Abasia, Joint Contracture, Pain, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Fibrosis, Injury, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, DRY Skin, Nephrogenic Systemic Fibrosis, Rash, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Scar, Mobility Decreased

Drug(s) suspected as cause:
Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-06-02
    End date: 2006-06-02

Optimark
    Indication: Muscular Weakness

Optimark
    Indication: Headache

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-05-28
    End date: 1999-05-28

Magnevist
    Indication: Renal Mass

Optimark
    Indication: Disorientation

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-05-21
    End date: 2004-05-21

Other drugs received by patient: Sensipar; Renvela; Prograf; Prednisone; Procrit; Phoslo; Lantus; Slow Release Iron; Atenolol; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]



Possible Optimark side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Hyperkeratosis, Pain, Skin Burning Sensation, Skin Hyperpigmentation, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Fibrosis, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, DRY Skin, Hypoaesthesia, Skin Induration, Deformity, Skin Tightness, Paraesthesia, Skin Plaque, Rash Macular, Gait Disturbance, Scar, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-04-14
    End date: 2005-04-14

Omniscan
    Dosage: 15 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-15
    End date: 2004-10-15

Prohance
    Dosage: 17 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2003-07-03
    End date: 2003-07-03

Magnevist

Omniscan
    Dosage: 30 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-07-13
    End date: 2004-07-13

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-04-14
    End date: 2005-04-14

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Optimark

Multihance

Other drugs received by patient: Calcitriol; Plavix; Fosrenol; Sensipar; Clonidine; Renvela; Rena-Vite; Calcium Carbonate; Metoprolol Tartrate; Renagel; Cozaar; Phoslo; Epogen; Hectorol; Iron; Amlodipine; Lisinopril; Proamatine; Foltx



Possible Optimark side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-01

Patient: 54 year old male, weighing 93.9 kg (206.5 pounds)

Reactions: Hyperkeratosis, Skin Exfoliation, Pain, Skin Hyperpigmentation, Scleroderma, Erythema, Joint Range of Motion Decreased, Oedema Peripheral, Skin Swelling, Rash Papular, General Physical Health Deterioration, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Sclerodactylia, Skin Tightness, Macule, Mobility Decreased

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 1999-10-13
    End date: 1999-10-13

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2007-03-21
    End date: 2007-03-21

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-11-18
    End date: 2008-11-18

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 1999-10-28
    End date: 1999-10-28

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-01-14
    End date: 2006-01-14

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 1999-09-20
    End date: 1999-09-20

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Fistulogram
    Start date: 1999-10-08
    End date: 1999-10-08

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-02-04
    End date: 2006-02-04

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-03-19
    End date: 2008-03-19

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-09-27
    End date: 1999-09-27

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-08-13
    End date: 2008-08-13

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Sensipar; Renal [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Aspirin; Hydrocodone Bitartrate + Acetaminophen; Phoslo; Calcium Acetate; Rena-Vite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Iron; Renvela



Possible Optimark side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-30

Patient: 56 year old female

Reactions: Joint Contracture, Pain, Abasia, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Depression, Injury, Extremity Contracture, Muscular Weakness, Skin Disorder, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Deformity, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Dermal Cyst, Mobility Decreased, Scar

Drug(s) suspected as cause:
Magnevist

Optimark
    Indication: Disorientation

Magnevist
    Dosage: unk
    Indication: Renal Mass
    Start date: 2004-05-21
    End date: 2004-05-21

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-06-02
    End date: 2006-06-02

Optimark
    Indication: Headache

Optimark
    Indication: Muscular Weakness

Other drugs received by patient: Renvela; Prednisone; Lantus; Sensipar; Atenolol; Prograf



Possible Optimark side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29

Patient: 56 year old female

Reactions: Pruritus, Abasia, Joint Contracture, Pain, Skin Hyperpigmentation, Ephelides, Joint Stiffness, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Depression, Fibrosis, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, Muscular Weakness, General Physical Health Deterioration, Skin Disorder, Skin Induration, Nephrogenic Systemic Fibrosis, Rash, DRY Skin, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Scar

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-05-21
    End date: 2004-05-21

Optimark
    Indication: Disorientation

Optimark
    Indication: Headache

Magnevist
    Indication: Renal Mass

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-06-02
    End date: 2006-06-02

Optimark
    Indication: Muscular Weakness

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-05-28
    End date: 1999-05-28

Other drugs received by patient: Lantus; Sensipar; Phoslo; Procrit; Renvela; Prograf; Atenolol; Slow Release Iron; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Prednisone TAB



Possible Optimark side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18

Patient: 50 year old male, weighing 69.8 kg (153.6 pounds)

Reactions: Muscle Contractions Involuntary, Pain, Skin Hyperpigmentation, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Arthralgia, Gait Disturbance, Skin Fibrosis, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Dosage: 30 ml, once
    Start date: 2000-05-05
    End date: 2000-05-05

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Start date: 2006-07-14
    End date: 2006-07-14

Magnevist
    Dosage: 48 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-02-05
    End date: 2000-02-05

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-12-17
    End date: 2001-12-17

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 39 ml, once
    Start date: 2006-07-26
    End date: 2006-07-26

Unspecified Gadolinium Based Contrast Agent
    Indication: Angiogram
    Start date: 2000-10-01
    End date: 2000-10-15

Magnevist
    Dosage: 40 ml, once
    Start date: 2006-08-09
    End date: 2006-08-09

Other drugs received by patient: Prednisone; Imuran; Norvasc; Calcium Carbonate; Micardis; Oxycet; Darbepoetin Alfa; Minoxidil; Percocet; Renagel; Digoxin; Clonidine; Phoslo; Lanthanum Carbonate; Ferrlecit; Florinef; Lopressor; Plaquenil; Procardia; Zemplar; Coreg; Amiodarone HCL; Aspirin; Cortisone Acetate; Renaphro; Epogen; Vancomycin; Darbepoetin Alfa; Hectorol; Fosrenol



Possible Optimark side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18

Patient: 50 year old male, weighing 69.8 kg (153.6 pounds)

Reactions: Muscle Contractions Involuntary, Pain, Skin Hyperpigmentation, Joint Stiffness, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Muscular Weakness, General Physical Health Deterioration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Arthralgia, Gait Disturbance, Mobility Decreased, Skin Fibrosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Unspecified Gadolinium Based Contrast Agent
    Indication: Angiogram
    Start date: 2000-10-01
    End date: 2000-10-15

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-12-17
    End date: 2001-12-17

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 48 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-02-05
    End date: 2000-02-05

Magnevist
    Dosage: 39 ml, once
    Start date: 2006-07-26
    End date: 2006-07-26

Magnevist
    Dosage: 30 ml, once
    Start date: 2000-05-05
    End date: 2000-05-05

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 40 ml, once
    Start date: 2006-08-09
    End date: 2006-08-09

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Start date: 2006-07-14
    End date: 2006-07-14

Other drugs received by patient: Epogen; Renagel; Procardia; Aspirin; Lopressor; Minoxidil; Ferrlecit; Zemplar; Coreg; Norvasc; Calcium Carbonate; Lanthanum Carbonate; Renaphro; Imuran; Digoxin; Florinef; Cortisone Acetate; Plaquenil; Micardis; Amiodarone HCL; Darbepoetin Alfa; Prednisone; Hectorol; Vancomycin; Darbepoetin Alfa; Phoslo; Fosrenol; Clonidine; Percocet; Oxycet



Possible Optimark side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-16

Patient: 56 year old female

Reactions: Pain, Joint Contracture, Abasia, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Depression, Extremity Contracture, Skin Disorder, Muscular Weakness, General Physical Health Deterioration, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Deformity, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Dermal Cyst, Mobility Decreased, Scar

Drug(s) suspected as cause:
Magnevist
    Indication: Renal Mass

Optimark
    Indication: Muscular Weakness

Optimark
    Indication: Disorientation

Optimark
    Indication: Headache

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-06-02
    End date: 2006-06-02

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-05-21
    End date: 2004-05-21

Other drugs received by patient: Sensipar; Atenolol; Prednisone TAB; Prograf; Renvela; Lantus



Possible Optimark side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-15

Patient: 56 year old female

Reactions: Pain, Abasia, Joint Contracture, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Injury, Depression, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, Nephrogenic Systemic Fibrosis, Skin Induration, DRY Skin, Deformity, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Dermal Cyst, Scar, Mobility Decreased

Drug(s) suspected as cause:
Magnevist

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-06-02
    End date: 2006-06-02

Optimark
    Indication: Headache

Optimark
    Indication: Disorientation

Magnevist
    Dosage: unk
    Indication: Renal Mass
    Start date: 2004-05-21
    End date: 2004-05-21

Optimark
    Indication: Muscular Weakness

Other drugs received by patient: Lantus; Sensipar; Prednisone; Atenolol; Prograf; Renvela



Possible Optimark side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-14

Patient: 64 year old male

Reactions: Rash Generalised, Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Emotional Distress, Anxiety, Skin Lesion, Injury, Mobility Decreased

Drug(s) suspected as cause:
Omniscan
    Indication: Product Used FOR Unknown Indication
    Start date: 2001-01-31
    End date: 2001-01-31

Omniscan
    Start date: 2003-02-27
    End date: 2003-02-27

Magnevist
    Indication: Product Used FOR Unknown Indication
    Start date: 2001-01-31
    End date: 2001-01-31

Magnevist
    Start date: 2003-02-27
    End date: 2003-02-27

Prohance
    Indication: Product Used FOR Unknown Indication

Optimark
    Indication: Product Used FOR Unknown Indication

Multihance
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Lanoxin; Coumadin; Nitroglycerin; Metoprolol Tartrate



Possible Optimark side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-02

Patient: 56 year old female

Reactions: Pain, Joint Contracture, Abasia, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Injury, Fibrosis, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, Skin Induration, DRY Skin, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Skin Plaque, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Scar

Drug(s) suspected as cause:
Magnevist

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-06-02
    End date: 2006-06-02

Optimark
    Indication: Disorientation

Optimark
    Indication: Muscular Weakness

Magnevist
    Dosage: unk
    Indication: Renal Mass
    Start date: 2004-05-21
    End date: 2004-05-21

Optimark
    Indication: Headache

Other drugs received by patient: Prograf; Sensipar; Prednisone; Atenolol; Renvela; Lantus



Possible Optimark side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-30

Patient: 43 year old male, weighing 118.0 kg (259.6 pounds)

Reactions: Pain in Extremity, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Fibrosis, Depression, Mobility Decreased, Scar

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-04-25
    End date: 2006-04-25

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: 20 ml, once
    Start date: 2006-05-21
    End date: 2006-05-21

Other drugs received by patient: Nephrocaps; Losartan Potassium; Aldactone; Insulin; Albumin (Human); Cardizem; Zemplar; Procardia XL; Aranesp; Catapres; Procrit; Phoslo



Possible Optimark side effects in 64 year old male

Reported by a lawyer from United States on 2012-04-19

Patient: 64 year old male

Reactions: Rash Generalised, Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Anxiety, Emotional Distress, Skin Lesion, Injury, Mobility Decreased

Drug(s) suspected as cause:
Omniscan
    Indication: Product Used FOR Unknown Indication
    Start date: 2001-01-31
    End date: 2001-01-31

Magnevist
    Start date: 2003-02-27
    End date: 2003-02-27

Multihance
    Indication: Product Used FOR Unknown Indication

Magnevist
    Indication: Product Used FOR Unknown Indication
    Start date: 2001-01-31
    End date: 2001-01-31

Omniscan
    Start date: 2003-02-27
    End date: 2003-02-27

Prohance
    Indication: Product Used FOR Unknown Indication

Optimark
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Nitroglycerin; Lanoxin; Coumadin; Metoprolol Tartrate



Possible Optimark side effects in 61 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-11

Patient: 61 year old male, weighing 160.9 kg (354.0 pounds)

Reactions: Thrombosis, Visual Acuity Reduced, Skin Hyperpigmentation, Hyperhidrosis, Dermatitis, Oedema Peripheral, Back Pain, Pain in Extremity, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Hypoaesthesia, Deformity, Tremor, Anxiety, Arthralgia, Scar

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-03-02
    End date: 2001-03-02

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain

Magnevist
    Dosage: unk unk, once
    Indication: Renal Mass
    Start date: 2004-03-29
    End date: 2004-03-29

Omniscan
    Indication: Imaging Procedure

Optimark
    Indication: Back Pain

Prohance
    Indication: Imaging Procedure

Optimark
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-02-22
    End date: 2006-02-22

Multihance
    Indication: Imaging Procedure

Other drugs received by patient: Warfarin Sodium; Bextra; Celebrex; Prilosec; Dynacirc; Testosterone; Vitamin B12 NOS; Ibuprofen; Flomax; Water Purified; Lortab; Viagra; NTP; Hydrochlorothiazide; Dovonex; Avapro; Prevacid; Vitamin B6; Aspirin



Possible Optimark side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-11

Patient: male, weighing 86.0 kg (189.2 pounds)

Reactions: Renal Disorder, Pain, Skin Disorder, General Physical Health Deterioration, Rash, Nephrogenic Systemic Fibrosis, Discomfort, Emotional Distress, Anxiety, Major Depression, Injury, Immobile, Mobility Decreased

Drug(s) suspected as cause:
Magnevist
    Dosage: 19 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2008-07-21
    End date: 2008-07-21

Gadolinium IN Unspecified Drug
    Indication: Angiogram

Omniscan
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-08-11
    End date: 2005-08-11

Gadolinium IN Unspecified Drug
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-05-21
    End date: 2005-05-21

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Dizziness
    Start date: 2006-10-23
    End date: 2006-10-23

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Asthenia

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Lyrica; Tamsulosin HCL; Dexamethasone; Warfarin Sodium; Silodosin; Amiodarone HCL; Norvasc; Actonel; Triamteren HCT; Hydralazine HCL; Iron Sulfatethiamin Compound TAB; Metoprolol Tartrate; Benicar; Omeprazole; Coreg; Metformin HCL; Simvastatin; Potassium



Possible Optimark side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-11

Patient: 54 year old male, weighing 93.9 kg (206.5 pounds)

Reactions: Hyperkeratosis, Skin Exfoliation, Pain, Joint Contracture, Scleroderma, Skin Hyperpigmentation, Erythema, Joint Range of Motion Decreased, Oedema Peripheral, Skin Swelling, Papule, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, DRY Skin, Deformity, Skin Plaque, Skin Tightness, Sclerodactylia, Macule

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-01-14
    End date: 2006-01-14

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 1999-10-28
    End date: 1999-10-28

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-08-13
    End date: 2008-08-13

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-11-18
    End date: 2008-11-18

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 1999-09-20
    End date: 1999-09-20

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2007-03-21
    End date: 2007-03-21

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Fistulogram
    Start date: 1999-10-08
    End date: 1999-10-08

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 1999-10-13
    End date: 1999-10-13

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-02-04
    End date: 2006-02-04

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-09-27
    End date: 1999-09-27

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-03-19
    End date: 2008-03-19

Other drugs received by patient: Rena-Vite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renvela; Phoslo; Calcium Acetate; Renal [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Acetaminophen and Hydrocodone Bitartrate; Iron; Sensipar; Aspirin



Possible Optimark side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-11

Patient: male, weighing 86.0 kg (189.2 pounds)

Reactions: Renal Disorder, Pain, General Physical Health Deterioration, Skin Disorder, Nephrogenic Systemic Fibrosis, Rash, Discomfort, Emotional Distress, Anxiety, Major Depression, Injury, Mobility Decreased, Immobile

Drug(s) suspected as cause:
Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 19 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2008-07-21
    End date: 2008-07-21

Magnevist
    Indication: Asthenia

Gadolinium IN Unspecified Drug
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-05-21
    End date: 2005-05-21

Gadolinium IN Unspecified Drug
    Indication: Angiogram

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Dizziness
    Start date: 2006-10-23
    End date: 2006-10-23

Omniscan
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-08-11
    End date: 2005-08-11

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Metoprolol Tartrate; Lyrica; Dexamethasone; Actonel; Triamteren HCT; Tamsulosin HCL; Omeprazole; Simvastatin; Amiodarone HCL; Iron Sulfatethiamin Compound TAB; Benicar; Norvasc; Hydralazine HCL; Warfarin Sodium; Metformin HCL; Silodosin; Coreg; Potassium



Possible Optimark side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-09

Patient: 57 year old female, weighing 66.0 kg (145.2 pounds)

Reactions: Pruritus, Skin Hyperpigmentation, Skin Discolouration, Skin Lesion, Skin Atrophy, Muscle Spasms, Peau D'orange, Pain in Extremity, Musculoskeletal Pain, Skin Disorder, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Hypopigmentation, Deformity, Skin Tightness, Arthralgia, Lichenification, Xerosis, Scar

Drug(s) suspected as cause:
Omniscan
    Indication: Imaging Procedure

Optimark
    Indication: Imaging Procedure

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-07-09
    End date: 2004-07-09

Magnevist

Multihance
    Indication: Imaging Procedure

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2002-05-20
    End date: 2002-05-20

Prohance
    Dosage: 15 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-01-14
    End date: 2003-01-14

Prohance
    Dosage: unk
    Start date: 2006-10-20
    End date: 2006-10-20

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2001-04-20
    End date: 2001-04-20

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-05-24
    End date: 2006-05-24

Other drugs received by patient: Ambien; Antiglaucoma Preparations and Miotics; Phenazopyridine HCL TAB; Tigan; MS Contin; Vibramycin; Lorcet-HD; MS Contin; Percocet; Xalatan; Antiglaucoma Preparations and Miotics; Antivert; Celexa; Augmentin '125'; Protonix; Ciprofloxacin HCL; Bactrim DS; Symbicort; Effexor; Mucinex; Depo; Orapred; Morphine Sulfate; Pyridiate; Singulair; Hycodan; Oxycontin; Combivent



Possible Optimark side effects in 45 year old male

Reported by a consumer/non-health professional from United States on 2012-04-05

Patient: 45 year old male, weighing 88.3 kg (194.4 pounds)

Reactions: Transplant Failure, Muscle Atrophy, Contusion, Hyperkalaemia, Unresponsive To Stimuli, Clostridium Difficile Colitis, Treatment Noncompliance, Balance Disorder, Oedema Peripheral, Blood Pressure Inadequately Controlled, Muscle Spasms, Ventricular Extrasystoles, Back Pain, Pneumonia, Cellulitis, Pain in Extremity, Renal Cancer, General Physical Health Deterioration, Lumbar Radiculopathy, Nephrogenic Systemic Fibrosis, Haemodialysis, Emotional Distress, Major Depression, Cholecystectomy, Mobility Decreased, Pain, Pallor, Pericardial Excision, Fall, Myalgia, Injury, Myocardial Infarction, Gouty Arthritis, Muscular Weakness, Rash, Discomfort, Anxiety, Sepsis, Gait Disturbance, Cardiac Arrest

Drug(s) suspected as cause:
Magnevist
    Indication: Angiogram
    Start date: 2007-02-05
    End date: 2007-02-05

Omniscan
    Indication: Product Used FOR Unknown Indication

Prohance
    Indication: Product Used FOR Unknown Indication

Multihance
    Indication: Product Used FOR Unknown Indication

Optimark
    Indication: Product Used FOR Unknown Indication

Gadolinium IN Unspecified Drug
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2002-11-20
    End date: 2002-11-20

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Iron Supplement; Plavix; Lipitor; Nifedipine; Hydralazine HCL; Alprazolam; Procardia; Coumadin; Epogen; Immunosuppressive Agents; Restoril; Multi-Vitamin; Digoxin; Prednisone 50mg TAB; Coreg; Neoral; Heart Medication (Nos); Amiodarone HCL; Effexor; Coumadin; Prednisone 50mg TAB; Hydrocodone; Lipitor; Lasix



Possible Optimark side effects in

Reported by a lawyer from United States on 2012-04-03

Patient:

Reactions: Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Fibrosis, Deformity, Mobility Decreased, Scar

Drug(s) suspected as cause:
Magnevist
    Indication: Imaging Procedure

Multihance
    Indication: Imaging Procedure

Prohance
    Indication: Imaging Procedure

Optimark
    Indication: Imaging Procedure

Omniscan
    Indication: Imaging Procedure



Possible Optimark side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-27

Patient: 54 year old male, weighing 93.9 kg (206.5 pounds)

Reactions: Gastrointestinal Haemorrhage, Hyperkeratosis, Morphoea, Pain, Erythema, Gastritis, Hand Deformity, Skin Discolouration, Oedema Peripheral, Lipoma, Emotional Disorder, Skin Swelling, Tendonitis, Haemorrhoids, Rash Papular, General Physical Health Deterioration, Patellofemoral Pain Syndrome, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Skin Hypertrophy, Renal Failure Chronic, Deformity, Skin Tightness, Haemodialysis, Sclerodactylia, Osteoarthritis, Mental Disorder

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 1999-09-20
    End date: 1999-09-20

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2007-03-21
    End date: 2007-03-21

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-02-04
    End date: 2006-02-04

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-11-18
    End date: 2008-11-18

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-01-14
    End date: 2006-01-14

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-09-27
    End date: 1999-09-27

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Fistulogram
    Start date: 1999-10-08
    End date: 1999-10-08

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 1999-10-13
    End date: 1999-10-13

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-08-13
    End date: 2008-08-13

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 1999-10-28
    End date: 1999-10-28

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-03-19
    End date: 2008-03-19

Other drugs received by patient: Calcium Acetate; Acetaminophen and Hydrocodone Bitartrate; Aspirin; Phoslo; Sensipar; Renal [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Rena-Vite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renvela; Iron



Possible Optimark side effects in male

Reported by a physician from United States on 2012-03-27

Patient: male, weighing 86.0 kg (189.2 pounds)

Reactions: Renal Disorder, Pain, Skin Disorder, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Rash, Discomfort, Anxiety, Emotional Distress, Major Depression, Injury, Immobile, Mobility Decreased

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Dizziness
    Start date: 2006-10-23
    End date: 2006-10-23

Gadolinium IN Unspecified Drug
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 19 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2008-07-21
    End date: 2008-07-21

Magnevist
    Indication: Asthenia

Omniscan
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-08-11
    End date: 2005-08-11

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-05-21
    End date: 2005-05-21

Other drugs received by patient: Actonel; Metoprolol Succinate; Benicar; Norvasc; Hydralazine HCL; Tamsulosin HCL; Iron Sulfatethiamin Compound TAB; Potassium; Triamteren HCT; Amiodarone HCL; Dexamethasone; Omeprazole; Lyrica; Silodosin; Metformin HCL; Simvastatin; Coreg; Warfarin Sodium



Possible Optimark side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-26

Patient: 56 year old female

Reactions: Pain, Abasia, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Fibrosis, Depression, Injury, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Anxiety, Emotional Distress, Arthralgia, Scar, Mobility Decreased

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Renal Mass
    Start date: 2004-05-21
    End date: 2004-05-21

Optimark
    Indication: Muscular Weakness

Optimark
    Indication: Headache

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-06-02
    End date: 2006-06-02

Optimark
    Indication: Disorientation

Magnevist

Other drugs received by patient: Sensipar; Prograf; Prednisone TAB; Atenolol; Renvela; Lantus



Possible Optimark side effects in

Reported by a lawyer from United States on 2012-03-22

Patient:

Reactions: Pain, General Physical Health Deterioration, Fibrosis, Nephrogenic Systemic Fibrosis, Deformity, Mobility Decreased, Scar

Drug(s) suspected as cause:
Prohance
    Indication: Imaging Procedure

Magnevist
    Indication: Imaging Procedure

Omniscan
    Indication: Imaging Procedure

Optimark
    Indication: Imaging Procedure

Multihance
    Indication: Imaging Procedure



Possible Optimark side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-20

Patient: female

Reactions: Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Fibrosis, Deformity, Scar, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Omniscan
    Indication: Imaging Procedure

Prohance
    Indication: Imaging Procedure

Magnevist
    Indication: Imaging Procedure

Optimark
    Indication: Imaging Procedure

Multihance
    Indication: Imaging Procedure



Possible Optimark side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-20

Patient: female

Reactions: Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Fibrosis, Deformity, Scar, Mobility Decreased

Drug(s) suspected as cause:
Optimark
    Indication: Imaging Procedure

Prohance
    Indication: Imaging Procedure

Omniscan
    Indication: Imaging Procedure

Multihance
    Indication: Imaging Procedure

Magnevist
    Indication: Imaging Procedure



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014